X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (674) 674
Publication (50) 50
Book Review (5) 5
Government Document (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (558) 558
female (442) 442
her2/neu (419) 419
oncology (354) 354
breast cancer (286) 286
receptor, erbb-2 - metabolism (238) 238
index medicus (230) 230
middle aged (191) 191
immunohistochemistry (189) 189
breast neoplasms - pathology (182) 182
cancer (175) 175
receptor, erbb-2 - genetics (173) 173
trastuzumab (173) 173
aged (162) 162
animals (161) 161
breast neoplasms - metabolism (150) 150
adult (149) 149
expression (140) 140
her2 (140) 140
prognosis (124) 124
breast neoplasms - genetics (123) 123
mice (121) 121
neu (110) 110
breast neoplasms - drug therapy (109) 109
antibodies, monoclonal, humanized (105) 105
monoclonal-antibody (103) 103
overexpression (101) 101
carcinoma (100) 100
cell line, tumor (100) 100
her-2/neu (98) 98
aged, 80 and over (95) 95
gene amplification (90) 90
pathology (89) 89
receptor, erbb-2 - immunology (87) 87
amplification (86) 86
her2/neu-overexpressing metastatic breast (86) 86
male (86) 86
antineoplastic agents - therapeutic use (81) 81
breast-cancer (81) 81
chemotherapy (80) 80
neu oncogene (80) 80
research (80) 80
in-situ hybridization (79) 79
oncogene (78) 78
ovarian-cancer (78) 78
tumor cells, cultured (78) 78
cell biology (75) 75
skin and connective tissue diseases (75) 75
tumors (73) 73
genes, erbb-2 (72) 72
antibodies, monoclonal - therapeutic use (71) 71
gene expression regulation, neoplastic (69) 69
medicine & public health (68) 68
receptor, erbb-2 - analysis (68) 68
receptor, erbb-2 - biosynthesis (68) 68
biochemistry & molecular biology (67) 67
apoptosis (65) 65
in situ hybridization, fluorescence (65) 65
survival (64) 64
therapy (63) 63
genetic aspects (62) 62
phase-ii (62) 62
antineoplastic agents - pharmacology (59) 59
gene expression (58) 58
care and treatment (55) 55
health aspects (54) 54
epidermal growth factor (52) 52
immunology (52) 52
growth-factor receptor (50) 50
neoplasm staging (50) 50
receptor, erbb-2 - antagonists & inhibitors (50) 50
analysis (49) 49
breast neoplasms - therapy (49) 49
proteins (48) 48
receptor (48) 48
genetics & heredity (47) 47
c-erbb-2 (46) 46
erbb-2 protein (46) 46
metastasis (46) 46
signal transduction (46) 46
cells (44) 44
neoplasms (44) 44
retrospective studies (44) 44
her2/ neu (43) 43
medicine, research & experimental (43) 43
article (42) 42
phosphorylation (41) 41
antibodies, monoclonal - pharmacology (40) 40
biomarkers, tumor - analysis (40) 40
protein (40) 40
erbb2 (39) 39
immunotherapy (39) 39
development and progression (38) 38
disease-free survival (36) 36
treatment outcome (36) 36
biomarkers, tumor - metabolism (35) 35
blotting, western (35) 35
breast neoplasms - immunology (35) 35
growth (35) 35
survival analysis (35) 35
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 08/2005, Volume 16, Issue 8, pp. 1253 - 1267
Background: Orlistat (Xenical(TM)), a US Food and Drug Administration (FDA)-approved drug for bodyweight loss, has recently been demonstrated to exhibit... 
Orlistat | PEA3 | Breast cancer | Fatty acid synthase | Her2/neu | Trastuzumab | POLY(ADP-RIBOSE) POLYMERASE | CARCINOMA PATIENTS | HER-2/NEU ERBB-2 | orlistat | TRASTUZUMAB HERCEPTIN | TYROSINE KINASE | CERULENIN ANALOGS | breast cancer | trastuzumab | ONCOLOGY | fatty acid synthase | NATURAL INHIBITOR | FATTY-ACID SYNTHASE | PROTEIN PALMITOYLATION | PHARMACOLOGICAL INHIBITION | fas Receptor | Luciferases - metabolism | Receptor, ErbB-2 - genetics | Apoptosis - drug effects | Humans | Receptor, ErbB-2 - metabolism | Immunoblotting | Promoter Regions, Genetic - genetics | Lactones - pharmacology | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Flow Cytometry | Lipase - antagonists & inhibitors | Receptors, Tumor Necrosis Factor - antagonists & inhibitors | Female | Transcription, Genetic | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Drug Therapy, Combination | Receptors, Tumor Necrosis Factor - genetics | Receptors, Tumor Necrosis Factor - metabolism | Antibodies, Monoclonal - pharmacology | Down-Regulation | RNA, Small Interfering - pharmacology | Breast Neoplasms - drug therapy | Drug Synergism | Transcription Factors - metabolism | Poly(ADP-ribose) Polymerases - metabolism | Cell Cycle - drug effects | Anti-Obesity Agents - pharmacology
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2008, Volume 8, Issue 1, pp. 377 - 377
Journal Article
Journal Article
Journal Article